Bio Essence Corp financial data

Symbol
BIOE on OTC
Industry
Pharmaceutical Preparations
Location
12 Chrysler Unit B, Irvine, CA
State of incorporation
CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 24.5 % +201%
Quick Ratio 6.07 % -5.3%
Debt-to-equity -199 % -16.3%
Return On Equity 75 % +75.3%
Return On Assets -75.4 % -26.1%
Operating Margin -143 % -74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38M shares 0%
Common Stock, Shares, Outstanding 38M shares 0%
Entity Public Float 1.27M USD 0%
Common Stock, Value, Issued 3.8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 38M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 38M shares +9.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 135K USD -13.5%
Cost of Revenue 53.7K USD -60.4%
General and Administrative Expense 1.4M USD +1404%
Operating Income (Loss) -1.1M USD -1176%
Nonoperating Income (Expense) -1.05M USD -4600%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.12M USD -1293%
Income Tax Expense (Benefit) 800 USD -50%
Net Income (Loss) Attributable to Parent -1.47M USD -48.8%
Earnings Per Share, Basic -0.03 USD/shares 0%
Earnings Per Share, Diluted -0.03 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.8K USD +33403%
Accounts Receivable, after Allowance for Credit Loss, Current 65.5K USD +399%
Inventory, Net 143K USD -20.9%
Assets, Current 716K USD +212%
Property, Plant and Equipment, Net 3.69K USD -98.5%
Operating Lease, Right-of-Use Asset 1.18M USD +20.8%
Intangible Assets, Net (Excluding Goodwill) 391 USD -37.5%
Other Assets, Noncurrent 391 USD
Assets 716K USD -65.1%
Accounts Payable, Current 32.1K USD -17.7%
Accrued Liabilities, Current 3.3K USD -51.1%
Liabilities, Current 3.07M USD +39.8%
Operating Lease, Liability, Noncurrent 535K USD -49.9%
Other Liabilities, Noncurrent 591K USD
Liabilities 3.66M USD +4.02%
Retained Earnings (Accumulated Deficit) -10.4M USD -16.5%
Stockholders' Equity Attributable to Parent -2.94M USD -101%
Liabilities and Equity 716K USD -65.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -172K USD +25.9%
Net Cash Provided by (Used in) Financing Activities 172K USD -23.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 23 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.8K USD +33403%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.7K USD -20.2%
Deferred Tax Assets, Valuation Allowance 653K USD -60.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 651K USD -60.5%
Operating Lease, Liability 1.39M USD
Depreciation 2.37K USD -84.4%
Lessee, Operating Lease, Liability, to be Paid 1.56M USD
Property, Plant and Equipment, Gross 56.5K USD -86.1%
Operating Lease, Liability, Current 911K USD +88.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 588K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 571K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 3.2K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 400K USD
Current Income Tax Expense (Benefit) 3.2K USD 0%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 7.48M USD 0%
Amortization of Intangible Assets 235 USD 0%
Depreciation, Depletion and Amortization 497 USD -80%
Interest Expense 542 USD -2.17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%